Association between procedure volume and 30-day mortality in stroke patients treated with EVT or IV rt-PA during the introduction period of EVT in Japan
Authors:
Open Access
- 30 June 2025
- journal article
- Published by National Center for Global Health and Medicine (JST) in Global Health & Medicine
- Vol. 7 (3) , 233-240
Abstract
This study aimed to determine whether procedure volume is associated with 30-day mortality following endovascular thrombectomy (EVT) or intravenous recombinant tissue plasminogen activator (IV rt-PA) for stroke during the introduction period of EVT in Japan. Using nationwide claims records, we investigated data from 8,227 patients undergoing EVT and 13,406 and 6,035 patients undergoing rt-PA monotherapy in hospitals with and without EVT capability, respectively, between April 2014 and February 2016 in Japan. Procedure volume was categorized into three groups according to tertiles of the annual number of EVTs or IV rt-PA injections performed in the hospitals. Hierarchical logistic regression demonstrated that the odds ratio (95% confidence interval) of 30-day mortality following EVT was significantly lower in middle- (0.77 [0.62–0.96]) and high- (0.69 [0.53–0.89]) volume hospitals than that in low-volume hospitals even after adjusting for potential confounding factors. The generalized additive mixed models revealed no obvious threshold volume of EVT to reduce the mortality risk. By contrast, mortality risk following IV rt-PA monotherapy did not decrease in hospitals without EVT capability but did with increasing IV rt-PA volume in hospitals with EVT capability (P for heterogeneity 0.003). The risk of 30-day mortality after EVT for acute ischemic stroke decreased linearly according to EVT procedure volume in each hospital. However, the association between IV rt-PA volume and mortality risk was modified by the hospital's EVT capability. Further research is warranted to determine whether the volume-outcome relationship we observed is a temporary phenomenon following EVT or a consistent trend over time.Keywords
This publication has 27 references indexed in Scilit:
- Nationwide temporal trend analysis of reperfusion therapy utilization and mortality in acute ischemic stroke patients in JapanMedicine, 2021
- Hospital Volume and Mortality in Acute Ischemic Stroke Patients: Effect of Adjustment for Stroke SeverityJournal of Stroke and Cerebrovascular Diseases, 2020
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015The Lancet, 2016
- Developing a stroke severity index based on administrative data was feasible using data mining techniquesJournal of Clinical Epidemiology, 2015
- Mechanical Thrombectomy in Acute Stroke: Utilization Variances and Impact of Procedural Volume on Inpatient MortalityJournal of Stroke and Cerebrovascular Diseases, 2013
- The Association of Hospital Volume With Mortality and Costs of Care for Stroke in JapanMedical Care, 2013
- Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic StrokeJAMA, 2013
- Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsThe Lancet, 2010
- Hospital Volume and 30-Day Mortality for Three Common Medical ConditionsNew England Journal of Medicine, 2010
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995